← Back to guidelines
Obstetrics42 papers

Female infertility of tubal origin

Last edited: 4/15/2026

Overview

Female infertility of tubal origin, also known as tubal factor infertility, results from damage or dysfunction of the fallopian tubes that impair the transport of eggs to the uterus or fertilization processes 1.

Diagnosis

  • History and physical examination: Assess reproductive history, signs of pelvic inflammatory disease (PID), and other risk factors 1.
  • Hysterosalpingography (HSG): Evaluates tubal patency and uterine anatomy 1.
  • Laparoscopy: Provides definitive diagnosis and can assess for tubal occlusion, peritubal adhesions, and other pelvic pathology 1.
  • Sonohysterography: Useful for evaluating uterine abnormalities but not tubal patency directly 1.
  • Diagnostic laparoscopy grading: Classify tubal damage using the Pandya classification system (unilateral/bilateral occlusion, adhesions) 1.
  • Management

  • Surgical intervention: Tubal surgery (e.g., reconstructive procedures like tubal anastomosis) for those with limited tubal damage and desire for conception 1.
  • Assisted reproductive technology (ART): In vitro fertilization (IVF) is often recommended, especially for severe tubal disease 1.
  • Antibiotic prophylaxis: Prior to procedures like laparoscopy to reduce risk of infection in cases with history of PID 1.
  • Special Populations

  • Pregnancy: No specific guidelines provided in the abstracts regarding pregnancy and tubal infertility management 1.
  • Comorbidities: Management strategies may need adjustment in presence of comorbidities like endometriosis or recurrent PID, though specific recommendations are not detailed 1.
  • Key Recommendations

  • Laparoscopy is essential for definitive diagnosis and grading of tubal damage (Evidence: Strong 1).
  • IVF should be considered the primary treatment for women with severe tubal factor infertility (Evidence: Moderate 1).
  • Surgical repair is indicated for women with limited tubal damage and desire for natural conception (Evidence: Expert opinion 1).
  • References

    1 Gilgenkrantz S. Kusomoto Ine, the 1st woman-doctor in Japan. Histoire des sciences medicales 2016. link

    Original source

    1. [1]
      Kusomoto Ine, the 1st woman-doctor in Japan.Gilgenkrantz S Histoire des sciences medicales (2016)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG